| |
e+CancerCare leadership includes both our management team and our board of directors. Comprised of highly experienced healthcare executives, our management team has a clear grasp of the outpatient cancer care industry gleaned from 60+ years of combined industry experience.
Robert A. Cucuel, Jr., Chairman of the Board
Robert has been affiliated with Kohlberg since 1999 and was named an Operating Partner in 2010. He has more than 25 years of experience as an executive in healthcare services and has served twice as Chief Executive Officer of Kohlberg portfolio companies. From 2006 until it was sold in 2010, Robert was the Chief Executive Officer of Critical Homecare Solutions, a Kohlberg Fund V portfolio company and a provider of home infusion therapy products and services. Prior to that he was the President and Chief Executive Officer of Air Products Healthcare, which had purchased American Homecare Supply, a Kohlberg Fund III portfolio company that he operated from 1998 until it was sold in 2002. He is currently Chairman of e+CancerCare. Prior to his affiliation with Kohlberg, Robert held various senior level management positions at American Home Patient and Home Nutritional Services. He is a graduate of Boston College.
Timothy M. Petrikin, Chief Executive Officer and Director
Tim co-founded e+CancerCare in 2002 with one
goal in mind: to develop and operate a best-in-class network
of integrated, outpatient cancer care centers backed by
a customer service culture reflective of the hospitality
industry. Prior to founding e+CancerCare in 2002, Tim
was the VP of Development for Ambulatory Resource Centres
(ARC), a venture capital-backed, ambulatory surgery center
company. He was involved from ARC’s inception in
1997 through its expansion to 38 centers and approximately $150
million in revenue. ARC merged with Symbion, Inc. (Nasdaq:
SMBI), a multi-specialty outpatient surgery center company,
in July 1999. Prior to that, he developed ambulatory surgery
and diagnostic imaging joint ventures for OrNda, a publicly
traded hospital management company acquired by Tenet Healthcare
in January 1997. While at OrNda and Symbion, Tim worked
extensively on establishing physician joint ventures. Tim
is a graduate of Oklahoma State University.
Amy Radcliff, President and Chief Operating Officer
Amy is responsible for the ongoing growth of current PET/CT centers, the management of key relationships with hospitals and physician groups, and continued business development of e+CancerCare’s new opportunities in radiation therapy and integrated cancer care centers. With more than 18 years of sales and sales management experience, Amy has developed and managed regional and national sales teams focused on organic growth of new technologies. Previously, Amy was district sales manager for Cable and Wireless PLC, a global Internet provider, where she developed a sales team dedicated to the sales of complex data and Internet solutions for Fortune 500 companies. Additionally, she spent 11 years developing a national accounts program for CUE Paging. After its acquisition, she managed the division for Satellink Communications. Amy is a graduate of the University of Missouri.
Robert B. Rhymer, Chief Clinical Operations Officer
Robbie is responsible for managing e+CancerCare’s diagnostics centers
operations. His healthcare industry experience includes more than 22 years
in both clinical and management roles. Previously, Robbie was regional VP of
Symbion, where he managed the Southeastern regional market and was instrumental
in the incremental growth of multiple surgery centers. He was also responsible
for maintaining quality of service and applying cost-effective methods to operations.
Early in his career, he held various positions at both Tenet Healthcare and
HCA, supervising departmental clinical operations and assessing and evaluating
improvements in patient care. Robbie graduated with an A.D. from Gardner Webb
University, a B.S.N. from Lenior-Rhyne College, and an M.S.N. from Duke University.
Lang Aston, Chief Financial Officer
Lang’s primary responsibilities are centered around raising capital and mergers and acquisitions. Before joining e+CancerCare, Lang was Managing Director and Head of Healthcare Investment Banking at Stephens Inc., an investment banking firm. While at Stephens, Lang served as the financial advisor for e+CancerCare. Lang has seventeen years of experience as an investment banker in the healthcare services sector, advising and facilitating more than 50 capital raises and strategic transactions. His career includes investment banking positions at Lehman Brothers, Bear Stearns, and Citicorp. Lang graduated from Duke University with a double major in civil engineering and economics. He also holds a Master’s degree in Business Administration from the University of Texas at Austin.
Bob Kinard, Chief Administrative Officer
Bob is responsible for managing the centralized business services and internal operations of the company. Prior to joining e+CancerCare, he was the Vice President and CFO of ConnectivHealth, a web-based platform company for health education and medical information. Previously, Bob served as Chief Corporate Development Officer with Passport Health Communications, a healthcare IT services company. Earlier in his career, Bob served as a Director in the Health Ventures practice of KPMG Peat Marwick LLP. He holds a Bachelor’s degree in Finance from Florida State University and an MBA from the University of Alabama.
Board of Directors
Our management team is supported by an equally experienced board of directors, whose professional expertise includes senior management positions with public and private healthcare entities and management of private equity and venture capital investments.
Charles N. Martin, Jr., CEO, Vanguard Health Systems
Charlie currently serves as the Chairman and CEO of Vanguard Health Systems, Inc. and is the former Chairman, President, and CEO of OrNda HealthCorp. Under his leadership, OrNda’s revenues grew from approximately $450 million to $3 billion in four years to become the nation’s third-largest investor-owned hospital management company. He currently sits on the board of Rand Corporation, a nonprofit institution that addresses the challenges facing public and private sectors around the world. His career includes serving as Director, President, and CEO of Healthtrust, Inc., as well as Director and Executive VP of HCA Inc.
Samuel P. Frieder, Managing Partner, Kohlberg
Samuel joined Kohlberg in 1989 and was named Managing Partner in 2006 and is a member of the Investment Committee. He is a member of the board of directors of AGY Holdings Corporation, Bauer Performance Sports, BioScrip, Centerplate, Central Parking Corporation, Chronos Life Group, Concrete Technologies Worldwide, e+CancerCare, Hoffmaster Group, Katy Industries, Kohlberg Capital Corporation, Kellermeyer Building Services, Niagara Corporation, Nielsen & Bainbridge, Packaging Dynamics Corporation, Pittsburgh Glass Works, Phillips Plastics Corporation, Stanadyne Corporation, SVP Holdings, Thomas Nelson, and Trico Products. Prior to joining Kohlberg, he was with the capital funding group at Security Pacific Business Credit and Manufacturers Hanover Trust Company. Samuel received his bachelor’s degree from Harvard College.
Gordon H. Woodward, Chief Investment Officer, Kohlberg
Gordon joined Kohlberg in 1996, became a Partner and a member of the Investment Committee in 2001 and was named Chief Investment Officer in 2010. He is a member of the board of directors of Bauer Performance Sports, BioScrip, Centerplate, Central Parking Corporation, Chronos Life Group, e+CancerCare, Hoffmaster Group, Kellermeyer Building Services, Nielsen & Bainbridge, Packaging Dynamics Corporation, Phillips Plastics Corporation, Stanadyne Corporation, and Thomas Nelson. Prior to joining Kohlberg, he was with James D. Wolfensohn Incorporated. Gordon received his bachelor’s degree from Harvard College.
Evan Wildstein, Partner, Kohlberg
Evan is a member of Kohlberg’s Investment Committee and is responsible for leading the execution and monitoring of certain new and existing Kohlberg investments. He joined Kohlberg in 1994, becoming a Partner in 1999. Prior to joining Kohlberg, he was with Dean Witter Reynolds in the Acquisition and Private Finance Group. He is a member of the board of directors of Chronos Life Group, e+CancerCare, Pittsburgh Glass Works, Stanadyne Corporation, SVP Holdings, and Trico Products. Mr. Wildstein holds a bachelor’s degree in business administration from the University of Michigan.
Benjamin J. Mao, Partner, Kohlberg
Benjamin is a member of Kohlberg’s Investment Committee and led the execution and monitoring of certain new and existing Kohlberg investments. After re-joining Kohlberg in 2002, he was named a Vice President in 2007 and a Partner in 2010. Benjamin was previously with Ewing Management Group and Donaldson, Lufkin & Jenrette and Credit Suisse First Boston. He is a member of the board of directors of e+CancerCare, Hoffmaster Group, Phillips Plastics Corporation, and Pittsburgh Glass Works. He received his bachelor’s degree from Harvard College.
George B. DeHuff III, Affiliate, Kohlberg
George has been affiliated with Kohlberg since 2001. He has more than 34 years of experience running businesses in both the healthcare and business service sectors. He served as President, CEO, and Executive Chairman for the Kohlberg portfolio company, B.I. Incorporated (“B.I.”), which he led through three consecutive leveraged buyouts until its eventual sale to The GEO Group in 2011. Prior to his affiliation with Kohlberg, he was President and COO of Total Renal Care, which at the time was the second largest provider of dialysis services in the U.S. He was also President and CEO of American Medical Response, now a division of EMSC, the largest provider of emergency medical services in the U.S. Prior to AMR, he was President and CEO at Lifefleet, Inc., one of the three largest private sector emergency medical services providers in the country at the time. Geoge has served in numerous leadership and operating roles at EECO, Price Waterhouse, and Hi-Tek Corporation. He is a member of the board of directors of AGY Holdings Corporation and e+CancerCare and has served on the boards of B.I. Incorporated and American Medical Response. George received his master’s degree in business administration from the University of Michigan and his bachelor’s degree in economics from Oakland University. |
|
